REGN
Price
$580.41
Change
+$14.44 (+2.55%)
Updated
Aug 15 closing price
Capitalization
61.52B
75 days until earnings call
TECH
Price
$53.60
Change
-$0.14 (-0.26%)
Updated
Aug 15 closing price
Capitalization
8.4B
80 days until earnings call
Interact to see
Advertisement

REGN vs TECH

Header iconREGN vs TECH Comparison
Open Charts REGN vs TECHBanner chart's image
Regeneron Pharmaceuticals
Price$580.41
Change+$14.44 (+2.55%)
Volume$1.12M
Capitalization61.52B
Bio-Techne
Price$53.60
Change-$0.14 (-0.26%)
Volume$1.31M
Capitalization8.4B
REGN vs TECH Comparison Chart in %
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. TECH commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Hold and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (REGN: $580.41 vs. TECH: $53.60)
Brand notoriety: REGN: Notable vs. TECH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 119% vs. TECH: 60%
Market capitalization -- REGN: $61.52B vs. TECH: $8.4B
REGN [@Biotechnology] is valued at $61.52B. TECH’s [@Biotechnology] market capitalization is $8.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than REGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 6 TA indicator(s) are bullish while TECH’s TA Score has 3 bullish TA indicator(s).

  • REGN’s TA Score: 6 bullish, 4 bearish.
  • TECH’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, REGN is a better buy in the short-term than TECH.

Price Growth

REGN (@Biotechnology) experienced а +3.09% price change this week, while TECH (@Biotechnology) price change was +6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

REGN is expected to report earnings on Oct 30, 2025.

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($61.5B) has a higher market cap than TECH($8.4B). TECH has higher P/E ratio than REGN: TECH (116.52) vs REGN (14.63). REGN YTD gains are higher at: -18.294 vs. TECH (-25.376). REGN has higher annual earnings (EBITDA): 5.42B vs. TECH (283M). REGN has more cash in the bank: 7.47B vs. TECH (141M). TECH has less debt than REGN: TECH (423M) vs REGN (2.71B). REGN has higher revenues than TECH: REGN (14.2B) vs TECH (1.21B).
REGNTECHREGN / TECH
Capitalization61.5B8.4B732%
EBITDA5.42B283M1,916%
Gain YTD-18.294-25.37672%
P/E Ratio14.63116.5213%
Revenue14.2B1.21B1,175%
Total Cash7.47B141M5,298%
Total Debt2.71B423M639%
FUNDAMENTALS RATINGS
REGN vs TECH: Fundamental Ratings
REGN
TECH
OUTLOOK RATING
1..100
1559
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5478
PRICE GROWTH RATING
1..100
6359
P/E GROWTH RATING
1..100
9512
SEASONALITY SCORE
1..100
4885

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (4) in the Biotechnology industry is in the same range as TECH (4). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

REGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TECH (100). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

REGN's SMR Rating (54) in the Biotechnology industry is in the same range as TECH (78). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

TECH's Price Growth Rating (59) in the Biotechnology industry is in the same range as REGN (63). This means that TECH’s stock grew similarly to REGN’s over the last 12 months.

TECH's P/E Growth Rating (12) in the Biotechnology industry is significantly better than the same rating for REGN (95). This means that TECH’s stock grew significantly faster than REGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
REGNTECH
RSI
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
55%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZSL23.190.04
+0.17%
ProShares UltraShort Silver
IDV36.790.05
+0.14%
iShares International Select Div ETF
SSUS46.37-0.12
-0.27%
Day Hagan Smart Sector ETF
MMTM275.51-1.46
-0.53%
SPDR® S&P 1500 Momentum Tilt ETF
OCFS27.26-0.15
-0.54%
Otter Creek Focus Strategy ETF